AKI associated with synthetic cannabinoids: a case series
- PMID: 23243266
- PMCID: PMC3613952
- DOI: 10.2215/CJN.05690612
AKI associated with synthetic cannabinoids: a case series
Abstract
SPICE, or K2, encompasses preparations of synthetic cannabinoids marketed as incense products, bath additives, and air fresheners and used for recreational purposes. These preparations are usually smoked for their cannabis-like effects and do not appear on routine urine toxicology screens. We report four cases of oliguric AKI associated with SPICE use in previously healthy men. All showed improvement in renal function without need for renal replacement therapy. Renal biopsy, performed in three of the patients, revealed acute tubular necrosis. The close temporal and geographic associations between the clinical presentation and the development of AKI strongly suggest an association between these SPICE preparations and AKI. Further investigations are required to identify the potential nephrotoxic agent(s). Nephrotoxicity from designer drugs should be included in the differential diagnosis of AKI, especially in young adults with negative urine drug screens.
Figures

References
-
- Johnson LA, Johnson RL, Alfonzo C: Spice: A legal marijuana equivalent. Mil Med 176: 718–720, 2011 - PubMed
-
- Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ: A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med 60: 435–438, 2012 - PubMed
-
- Müller H, Sperling W, Köhrmann M, Huttner HB, Kornhuber J, Maler J-M: The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophr Res 118: 309–310, 2010 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources